Skip to ContentSkip to Navigation
About us Latest news News News articles

Signal transduction pathways in hepatocyte cell death. New targets for therapy

07 May 2012

PhD ceremony: Ms. G. Karimian, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Signal transduction pathways in hepatocyte cell death. New targets for therapy

Promotor(s): prof. A.J. Moshage, prof. K.N. Faber

Faculty: Medical Sciences

Cholestatic and steatotic liver diseases comprise a significant share of the total burden of chronic liver diseases. Both diseases are associated with a high morbidity and mortality. Existing therapeutic agents are either not very effective or are associated with severe difficulties. Both groups of diseases are characterized by a gradual and progressive loss of viable hepatocytes leading to liver inflammation, fibrogenesis and end-stage liver disease. Hepatocyte cell death can occur via either apoptosis or necrosis (or intermediate forms). Knowledge about the cellular mechanisms regulating death and survival of liver cells is of clinical and scientific interest for developing new therapeutic strategies. The aim of this thesis is to elucidate the mechanisms of cell death in hepatocytes, in order to develop strategies to protect hepatocytes and prevent liver injury.

Three models of hepatocyte cell death were studied: glycochenodeoxycholic acid (GCDCA)-induced cell death as a model for bile acid toxicity, tumor necrosis factor α (TNFα)/ actinomycin D (ActD, an inhibitor of transcription) as a model for cytokine-induced toxicity and menadione-induced cell death (menadione is a superoxide anion donor) as a model for oxidative stress-induced toxicity. These models are clinically relevant as these toxic stimuli are present at increased levels in most liver diseases. This thesis describes that hepatocyte death and survival are regulated at the cross-roads of intracellular organelles (e.g., mitochondria and endoplasmic reticulum), membrane-bound receptors (such as GPCRs and EGFR) and cell survival signaling pathways (such as ERK, PI3K and PKC).

Last modified:13 March 2020 12.59 a.m.
View this page in: Nederlands

More news

  • 29 November 2023

    UMCG opent nieuwe faciliteit voor microbioomonderzoek 

    Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...

  • 28 November 2023

    Science: more exciting than showbiz

    Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...

  • 13 November 2023

    UMCG beantwoordt vragen patiënten met hulp van AI

    Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...